Joon Lee
Stock Analyst at Truist Securities
(4.68)
# 175
Out of 4,876 analysts
121
Total ratings
55.56%
Success rate
41.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SAGE Sage Therapeutics | Maintains: Hold | $8 → $9 | $9.28 | -3.02% | 12 | Jun 17, 2025 | |
| PTCT PTC Therapeutics | Initiates: Buy | $80 | $49.55 | +61.45% | 1 | Jun 17, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $28.17 | +166.24% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $7.80 | +169.23% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $74.33 | +101.80% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $9.61 | +420.29% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $44.26 | +92.05% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $102.57 | +94.99% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $46.70 | +156.96% | 5 | Feb 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $460 → $520 | $443.40 | +17.28% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.08 | +484.42% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $660 → $700 | $560.04 | +24.99% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 → $57 | $94.40 | -39.62% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.81 | +232.64% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $7.03 | +412.09% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $21.89 | +64.46% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.12 | +277.36% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $14.96 | +13.64% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $54.10 | +66.36% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $2.49 | +1,506.43% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $107.59 | +85.89% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $2.41 | +107.47% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.97 | +506.06% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.81 | +9,873.64% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $23.38 | +45.42% | 1 | Mar 16, 2021 |
Sage Therapeutics
Jun 17, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $9.28
Upside: -3.02%
PTC Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $80
Current: $49.55
Upside: +61.45%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $28.17
Upside: +166.24%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $7.80
Upside: +169.23%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $74.33
Upside: +101.80%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $9.61
Upside: +420.29%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $44.26
Upside: +92.05%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $102.57
Upside: +94.99%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $46.70
Upside: +156.96%
Vertex Pharmaceuticals
Feb 11, 2025
Maintains: Buy
Price Target: $460 → $520
Current: $443.40
Upside: +17.28%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.08
Upside: +484.42%
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $560.04
Upside: +24.99%
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $94.40
Upside: -39.62%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $4.81
Upside: +232.64%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $7.03
Upside: +412.09%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $21.89
Upside: +64.46%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.12
Upside: +277.36%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $14.96
Upside: +13.64%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $54.10
Upside: +66.36%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $2.49
Upside: +1,506.43%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $107.59
Upside: +85.89%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $2.41
Upside: +107.47%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $2.97
Upside: +506.06%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.81
Upside: +9,873.64%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $23.38
Upside: +45.42%